血友病A及びB：企業と競争環境...市場調査レポートについてご紹介

1 Table of Contents
1 Table of Contents 6
1.1 List of Tables 7
1.2 List of Figures 8
2 Introduction 9
2.1 Catalyst 9
2.2 Related Reports 10
2.3 Upcoming Related Reports 12
3 Market Outlook 13
3.1 Global Markets 13
3.1.1 Forecast 13
3.1.2 Drivers and Barriers – Global Issues 17
4 Current and Future Players 20
4.1 Overview 20
4.2 Trends in Corporate Strategy 22
4.3 Company Profiles 23
4.3.1 Baxter 23
4.3.2 Biogen Idec 27
4.3.3 Novo Nordisk 29
4.3.4 CSL Behring 32
4.3.5 Bayer 33
4.3.6 Pfizer 35
5 Appendix 37
5.1 Bibliography 37
5.2 Abbreviations 39
5.3 Methodology 40
5.4 Forecasting Methodology 40
5.4.1 Diagnosed Hemophilia Patients 40
5.4.2 Percent Drug-Treated Patients 41
5.4.3 Drugs Included in Each Therapeutic Class 41
5.4.4 General Pricing Assumptions 42
5.5 Physicians and Specialists Included in this Study 43
5.6 About the Authors 45
5.6.1 Authors 45
5.6.2 Global Head of Healthcare 46
5.7 About GlobalData 47
5.8 Disclaimer 47